Spruce Biosciences Reports Q2 2026 Financial Results

What Happened Spruce Biosciences, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release issued on August 12, 2026. The company furnished the full text of the press release as Exhibit 99.1 to its Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Date filed: August 12, 2026. Quarter reported: ended June 30, 2026.
• Disclosure type: Item 2.02 — the company furnished a press release with its quarterly results and corporate updates.
• Exhibit: Full text of the press release is furnished as Exhibit 99.1 to the 8-K.
• Legal note: The items furnished (including Exhibit 99.1) are explicitly stated not to be “filed” for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other filings except by specific reference.

Why It Matters This 8-K signals that Spruce has released its latest quarterly operating and financial information; those details (revenue, net income/loss, cash position, guidance, and any corporate updates) are contained in the press release. Investors should review Exhibit 99.1 and the company’s other SEC filings to see the actual financial figures and any management commentary that could affect valuation or near-term expectations.